We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19) (CCOVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04535869
Recruitment Status : Unknown
Verified August 2020 by Mahmoud Elbendary, Mansoura University.
Recruitment status was:  Recruiting
First Posted : September 2, 2020
Last Update Posted : February 24, 2021
Information provided by (Responsible Party):
Mahmoud Elbendary, Mansoura University